A review of psilocybin therapy for terminal patients becomes more relevant in light of recent research from Compass Pathways.
Veterans Administration medical centers across the country are creating and deploying protocols for psychedelic therapy.
Amid record overdose deaths, New York City has opened the first overdose prevention centers despite mixed signals from the Biden Administration.
Participants who had experienced childhood abuse and used psychedelics with therapeutic intent reported feeling less internalized shame.
The new kit uses the Morris reagent, the only known chemical that reacts to the presence of ketamine.
A national drug survey of U.S. adolescents and adults found that psychedelic use among young adults has reached its highest levels since 1982.
As psychedelic-assisted therapies enter the medical and pharmaceutical mainstream, some scientists are pushing back against a mystical mindset that permeates much of this growing movement.
The results suggest that despite differences in pharmacology, there may be a role for cannabis in the emerging psychedelic therapy paradigm alongside tryptamine psychedelics.
Following its decriminalization of psilocybin, the city will educate and support police departments, fire departments, paramedics and more to help citizens experiencing a challenging time with psychedelics.
A new review paper finds that most potential psychiatric drug and psychedelics combinations pose mild to modest risks – but the exceptions, which can be serious, are important to understand.